- Home
- APRE vs PETZ Comparison
APRE vs PETZ Comparison
Compare APRE & PETZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APRE
- PETZ
- Stock Information
- Founded
- APRE 2006
- PETZ 2002
- Country
- APRE United States
- PETZ China
- Employees
- APRE N/A
- PETZ N/A
- Industry
- APRE Biotechnology: Biological Products (No Diagnostic Substances)
- PETZ Steel/Iron Ore
- Sector
- APRE Health Care
- PETZ Industrials
- Exchange
- APRE Nasdaq
- PETZ Nasdaq
- Market Cap
- APRE 13.5M
- PETZ 12.9M
- IPO Year
- APRE 2019
- PETZ 2017
- Fundamental
- Price
- APRE $1.80
- PETZ $1.12
- Analyst Decision
- APRE Strong Buy
- PETZ
- Analyst Count
- APRE 2
- PETZ 0
- Target Price
- APRE $15.50
- PETZ N/A
- AVG Volume (30 Days)
- APRE 21.0K
- PETZ 8.7K
- Earning Date
- APRE 05-13-2025
- PETZ 04-28-2025
- Dividend Yield
- APRE N/A
- PETZ N/A
- EPS Growth
- APRE N/A
- PETZ N/A
- EPS
- APRE N/A
- PETZ N/A
- Revenue
- APRE $1,502,581.00
- PETZ $3,278,453.00
- Revenue This Year
- APRE N/A
- PETZ N/A
- Revenue Next Year
- APRE N/A
- PETZ N/A
- P/E Ratio
- APRE N/A
- PETZ N/A
- Revenue Growth
- APRE 157.63
- PETZ 2.46
- 52 Week Low
- APRE $1.85
- PETZ $1.03
- 52 Week High
- APRE $6.70
- PETZ $1.74
- Technical
- Relative Strength Index (RSI)
- APRE 26.70
- PETZ 32.84
- Support Level
- APRE $1.85
- PETZ $1.10
- Resistance Level
- APRE $2.30
- PETZ $1.41
- Average True Range (ATR)
- APRE 0.16
- PETZ 0.08
- MACD
- APRE -0.01
- PETZ -0.03
- Stochastic Oscillator
- APRE 2.50
- PETZ 3.23
About APRE Aprea Therapeutics Inc. Common stock
Aprea Therapeutics Inc is a clinical-stage biopharmaceutical company. The group is focused on precision oncology through synthetic lethality. Its pipeline product is ATRN-119, a clinical-stage small molecule ATR inhibitor in development for solid tumor indications. APR-1051, an oral, small-molecule WEE1 inhibitor, recently entered the clinic.
About PETZ TDH Holdings Inc.
TDH Holdings Inc is engaged in the business of manufacturing and selling of petfood and restaurant operations. The company has two operating segments which include Petfood sales and Restaurant business. It has a focus on the Restaurant business segment and generates the majority of its revenue.